METTL14 Mediates Glut3 m6A methylation to improve osteogenesis under oxidative stress condition
Objectives Bone remodeling imbalance contributes to osteoporosis. Though current medications enhance osteoblast involvement in bone formation, the underlying pathways remain unclear. This study was aimed to explore the pathways involved in bone formation by osteoblasts, we investigate the protective...
Saved in:
Main Authors: | Ying Wang, Xueying Yu, Fenyong Sun, Yan Fu, Tingting Hu, Qiqing Shi, Qiuhong Man |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Redox Report |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/13510002.2024.2435241 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancer
by: Chenlin Liu, et al.
Published: (2025-01-01) -
METTL14 modulates the progression and ferroptosis of colitis by regulating the stability of m6A-modified GPX4
by: Yuhua Chen, et al.
Published: (2025-02-01) -
METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer
by: Lijie Li, et al.
Published: (2024-12-01) -
METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy
by: Xuefen Zhuang, et al.
Published: (2024-12-01) -
METTL3 as a potential therapeutic target in gastric cancer
by: Zhefei Yu, et al.
Published: (2024-11-01)